<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: molecular pharmacology</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Breakthrough in how pancreatic cancer cells ingest nutrients points to new drug target</title>
   	 <description>In a landmark cancer study published online in Nature, researchers at NYU School of Medicine have unraveled a longstanding mystery about how pancreatic tumor cells feed themselves, opening up new therapeutic possibilities for a notoriously lethal disease with few treatment options. Pancreatic cancer kills nearly 38,000 Americans annually, making it a leading cause of cancer death. The life expectancy for most people diagnosed with it is less than a year.</description>
     <link>http://medicalxpress.com/news/2013-05-breakthrough-pancreatic-cancer-cells-ingest.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 13 May 2013 16:47:33 EST</pubDate>
	 <guid isPermaLink="false">news287682443</guid>
	 
</item>
<item>
     <title>Brain region may hold key to aging</title>
   	 <description>While the search continues for the Fountain of Youth, researchers may have found the body's &quot;fountain of aging&quot;: the brain region known as the hypothalamus. For the first time, scientists at Albert Einstein College of Medicine of Yeshiva University report that the hypothalamus of mice controls aging throughout the body. Their discovery of a specific age-related signaling pathway opens up new strategies for combating diseases of old age and extending lifespan. The paper was published today in the online edition of Nature.</description>
     <link>http://medicalxpress.com/news/2013-05-brain-region-key-aging.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Wed, 01 May 2013 13:00:16 EST</pubDate>
	 <guid isPermaLink="false">news286626225</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/brain.gif" width="90" height="96" />
</item>
<item>
     <title>New monoclonal antibody developed that can target proteins inside cancer cells</title>
   	 <description>Researchers have discovered a unique monoclonal antibody that can effectively reach inside a cancer cell, a key goal for these important anticancer agents, since most proteins that cause cancer or are associated with cancer are buried inside cancer cells. Scientists from Memorial Sloan-Kettering Cancer Center and Eureka Therapeutics have collaborated to create the new human monoclonal antibody, which targets a protein associated with many types of cancer and is of great interest to cancer researchers.</description>
     <link>http://medicalxpress.com/news/2013-03-monoclonal-antibody-proteins-cancer-cells.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 13 Mar 2013 14:15:59 EST</pubDate>
	 <guid isPermaLink="false">news282402953</guid>
	 
</item>
<item>
     <title>Researchers reveal mechanism to halt cancer cell growth, discover potential therapy</title>
   	 <description>University of Pittsburgh Cancer Institute (UPCI) researchers have uncovered a technique to halt the growth of cancer cells, a discovery that led them to a potential new anti-cancer therapy.</description>
     <link>http://medicalxpress.com/news/2013-02-reveal-mechanism-halt-cancer-cell.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 04 Feb 2013 04:30:27 EST</pubDate>
	 <guid isPermaLink="false">news279174611</guid>
	 
</item>
<item>
     <title>Preventing prostate cancer through androgen deprivation may have harmful effects</title>
   	 <description>Mice deficient in PTEN in the prostate developed stable precancers. Androgen deprivation promoted progression to invasive prostate cancer. Patients with PTEN-deficient prostate precancers may not benefit from androgen deprivation chemoprevention therapy.</description>
     <link>http://medicalxpress.com/news/2012-12-prostate-cancer-androgen-deprivation-effects.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 20 Dec 2012 10:39:48 EST</pubDate>
	 <guid isPermaLink="false">news275222382</guid>
	 
</item>
<item>
     <title>Researchers discover adverse effects of Bisphenol A on calcium channels</title>
   	 <description>(Medical Xpress)—Bisphenol A, a substance found in many synthetic products, is considered to be harmful, particularly, for fetuses and babies. Researchers from the University of Bonn have now shown in experiments on cells from human and mouse tissue that this environmental chemical blocks calcium channels in cell membranes. Similar effects are elicited by drugs used to treat high blood pressure and cardiac arrhythmia. The results are now presented in the journal Molecular Pharmacology.</description>
     <link>http://medicalxpress.com/news/2012-12-adverse-effects-bisphenol-calcium-channels.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 06 Dec 2012 08:11:37 EST</pubDate>
	 <guid isPermaLink="false">news274003814</guid>
	 
</item>
<item>
     <title>New mechanism of action for PARP inhibitors discovered</title>
   	 <description>New understanding of how drugs called PARP inhibitors, which have already shown promise for the treatment of women with familial breast and ovarian cancers linked to BRCA mutations, exert their anticancer effects has led to the identification of ways in which the patient population that might benefit from PARP inhibitors could be expanded.</description>
     <link>http://medicalxpress.com/news/2012-11-mechanism-action-parp-inhibitors.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 09 Nov 2012 11:29:43 EST</pubDate>
	 <guid isPermaLink="false">news271682973</guid>
	 
</item>
<item>
     <title>New drug could treat Alzheimer's, multiple sclerosis and brain injury</title>
   	 <description>A new class of drug developed at Northwestern University Feinberg School of Medicine shows early promise of being a one-size-fits-all therapy for Alzheimer's disease, Parkinson's disease, multiple sclerosis and traumatic brain injury by reducing inflammation in the brain.</description>
     <link>http://medicalxpress.com/news/2012-07-drug-alzheimer-multiple-sclerosis-brain.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Tue, 24 Jul 2012 17:09:11 EST</pubDate>
	 <guid isPermaLink="false">news262368535</guid>
	 
</item>
<item>
     <title>Scientists solve 1,000 protein structures from infectious disease organisms</title>
   	 <description>Investigators at the Center for Structural Genomics of Infectious Diseases (CSGID) and the Seattle Structural Genomics Center for Infectious Disease (SSGCID) announced today that they reached a significant milestone by determining 1,000 protein structures from infectious disease organisms. The knowledge gained from these structures should lead to new interventions for the deadly diseases caused by these pathogens.</description>
     <link>http://medicalxpress.com/news/2012-06-scientists-protein-infectious-disease.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 05 Jun 2012 15:54:04 EST</pubDate>
	 <guid isPermaLink="false">news258130413</guid>
	 
</item>
<item>
     <title>Purdue researchers reveal role of protein mutation in Parkinson's disease</title>
   	 <description>Purdue University researchers revealed how a mutation in a protein shuts down a protective function needed to prevent the death of neurons in Parkinson's disease, possibly opening the door to new drug strategies to treat the disorder.</description>
     <link>http://medicalxpress.com/news/2012-02-purdue-reveal-role-protein-mutation.html</link>
	 <category>Parkinson's &amp; Movement disorders</category>
	 <pubDate>Tue, 21 Feb 2012 12:39:26 EST</pubDate>
	 <guid isPermaLink="false">news249050344</guid>
	 
</item>
<item>
     <title>US Patent Office affirms 'Zamore Design Rule' patents</title>
   	 <description>The United States Patent and Trademark Office has reaffirmed the validity of four important patents in the field of RNA therapeutics. </description>
     <link>http://medicalxpress.com/news/2011-12-patent-office-affirms-zamore-patents.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 12 Dec 2011 16:38:43 EST</pubDate>
	 <guid isPermaLink="false">news242930311</guid>
	 
</item>
<item>
     <title>New protocols improve detection of microRNAs for diagnosis</title>
   	 <description>MicroRNAs (miRNAs) that regulate processes including fertilization, development, and aging show promise as biomarkers of disease. They can be collected from routinely collected fluids such as blood, saliva, and urine. However, a number of factors can interfere with the accuracy of miRNA tests. In a study published online today in the Journal of Molecular Diagnostics, a group of researchers provide clear procedures for the collection and analysis of miRNA, significantly improving their diagnostic accuracy.</description>
     <link>http://medicalxpress.com/news/2011-12-protocols-micrornas-diagnosis.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 07 Dec 2011 04:49:25 EST</pubDate>
	 <guid isPermaLink="false">news242455755</guid>
	 
</item>
<item>
     <title>Tumor-targeting compound points the way to new personalized cancer treatments</title>
   	 <description>One major obstacle in the fight against cancer is that anticancer drugs often affect normal cells in addition to tumor cells, resulting in significant side effects. Yet research into development of less harmful treatments geared toward the targeting of specific cancer-causing mechanisms is hampered by lack of knowledge of the molecular pathways that drive cancers in individual patients.</description>
     <link>http://medicalxpress.com/news/2011-12-tumor-targeting-compound-personalized-cancer-treatments.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 01 Dec 2011 16:00:01 EST</pubDate>
	 <guid isPermaLink="false">news241977044</guid>
	 
</item>
<item>
     <title>Moderate drinking protects against Alzheimer's and cognitive impairment</title>
   	 <description>Moderate social drinking significantly reduces the risk of dementia and cognitive impairment, according to an analysis of 143 studies by Loyola University Chicago Stritch School of Medicine researchers.</description>
     <link>http://medicalxpress.com/news/2011-08-moderate-alzheimer-cognitive-impairment.html</link>
	 <category>Addiction</category>
	 <pubDate>Tue, 16 Aug 2011 09:15:23 EST</pubDate>
	 <guid isPermaLink="false">news232704904</guid>
	 
</item>
<item>
     <title>New research challenges our understanding of cell communication</title>
   	 <description>Cells often communicate with one another using pulsatile signals, where information is conveyed in pulse frequency as well as amplitude. This raises the question of how cells decode pulsatile signals, a question that lies at the core of our understanding of how the brain controls reproduction.</description>
     <link>http://medicalxpress.com/news/2011-08-cell.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 03 Aug 2011 03:51:37 EST</pubDate>
	 <guid isPermaLink="false">news231562133</guid>
	 
</item>


</channel>
</rss>
